In the news | 6th January 2014

Banking on biologics

American Laboratory

January 2014

Biologics means big bucks and big rewards. The pharma industry is keen to capitalize on this success as revenues are tipped to reach over $407 billion by 2018. By this time, more than 50% of the top 100 selling drugs will be biologics.

Read the full article here »

About IDBSContact us

More news

i3 2021 On Demand

i3 our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation and this year we went virtual. During i3 you will gain insights from your peers…

Read more